152 related articles for article (PubMed ID: 22749991)
1. Postconditioning with curaglutide, a novel GLP-1 analog, protects against heart ischemia-reperfusion injury in an isolated rat heart.
Salling HK; Döhler KD; Engstrøm T; Treiman M
Regul Pept; 2012 Oct; 178(1-3):51-5. PubMed ID: 22749991
[TBL] [Abstract][Full Text] [Related]
2. Novel fusion of GLP-1 with a domain antibody to serum albumin prolongs protection against myocardial ischemia/reperfusion injury in the rat.
Bao W; Holt LJ; Prince RD; Jones GX; Aravindhan K; Szapacs M; Barbour AM; Jolivette LJ; Lepore JJ; Willette RN; DeAngelis E; Jucker BM
Cardiovasc Diabetol; 2013 Oct; 12():148. PubMed ID: 24125539
[TBL] [Abstract][Full Text] [Related]
3. Protective effects of GLP-1 analogues exendin-4 and GLP-1(9-36) amide against ischemia-reperfusion injury in rat heart.
Sonne DP; Engstrøm T; Treiman M
Regul Pept; 2008 Feb; 146(1-3):243-9. PubMed ID: 17976835
[TBL] [Abstract][Full Text] [Related]
4. The cardioprotective and inotropic components of the postconditioning effects of GLP-1 and GLP-1(9-36)a in an isolated rat heart.
Ossum A; van Deurs U; Engstrøm T; Jensen JS; Treiman M
Pharmacol Res; 2009 Nov; 60(5):411-7. PubMed ID: 19540343
[TBL] [Abstract][Full Text] [Related]
5. Postconditioning with glucagon like peptide-2 reduces ischemia/reperfusion injury in isolated rat hearts: role of survival kinases and mitochondrial KATP channels.
Penna C; Pasqua T; Perrelli MG; Pagliaro P; Cerra MC; Angelone T
Basic Res Cardiol; 2012 Jul; 107(4):272. PubMed ID: 22699364
[TBL] [Abstract][Full Text] [Related]
6. Glucagon-like peptide (GLP)-1(9-36)amide-mediated cytoprotection is blocked by exendin(9-39) yet does not require the known GLP-1 receptor.
Ban K; Kim KH; Cho CK; Sauvé M; Diamandis EP; Backx PH; Drucker DJ; Husain M
Endocrinology; 2010 Apr; 151(4):1520-31. PubMed ID: 20172966
[TBL] [Abstract][Full Text] [Related]
7. Albiglutide, a long lasting glucagon-like peptide-1 analog, protects the rat heart against ischemia/reperfusion injury: evidence for improving cardiac metabolic efficiency.
Bao W; Aravindhan K; Alsaid H; Chendrimada T; Szapacs M; Citerone DR; Harpel MR; Willette RN; Lepore JJ; Jucker BM
PLoS One; 2011; 6(8):e23570. PubMed ID: 21887274
[TBL] [Abstract][Full Text] [Related]
8. Cardioprotective Effects of Mitochondria-Targeted Peptide SBT-20 in two Different Models of Rat Ischemia/Reperfusion.
Dai W; Cheung E; Alleman RJ; Perry JB; Allen ME; Brown DA; Kloner RA
Cardiovasc Drugs Ther; 2016 Dec; 30(6):559-566. PubMed ID: 27747447
[TBL] [Abstract][Full Text] [Related]
9. Cardioprotective effects of lixisenatide in rat myocardial ischemia-reperfusion injury studies.
Wohlfart P; Linz W; Hübschle T; Linz D; Huber J; Hess S; Crowther D; Werner U; Ruetten H
J Transl Med; 2013 Mar; 11():84. PubMed ID: 23537041
[TBL] [Abstract][Full Text] [Related]
10. KR-31762, a novel KATP channel opener, exerts cardioprotective effects by opening SarcKATP channels in rat models of ischemia/reperfusion-induced heart injury.
Lee SH; Yang MK; Lim JH; Seo HW; Yi KY; Yoo SE; Lee BH; Won HS; Lee CS; Choi WS; Shin HS
Arch Pharm Res; 2008 Apr; 31(4):482-9. PubMed ID: 18449506
[TBL] [Abstract][Full Text] [Related]
11. PET of glucagonlike peptide receptor upregulation after myocardial ischemia or reperfusion injury.
Gao H; Kiesewetter DO; Zhang X; Huang X; Guo N; Lang L; Hida N; Wang H; Wang H; Cao F; Niu G; Chen X
J Nucl Med; 2012 Dec; 53(12):1960-8. PubMed ID: 23139087
[TBL] [Abstract][Full Text] [Related]
12. Antidiabetic Drug Alogliptin Protects the Heart Against Ischemia-reperfusion Injury Through GLP-1 Receptor-dependent and Receptor-independent Pathways Involving Nitric Oxide Production in Rabbits.
Baba S; Iwasa M; Higashi K; Minatoguchi S; Yamada Y; Kanamori H; Kawasaki M; Nishigaki K; Minatoguchi S
J Cardiovasc Pharmacol; 2017 Dec; 70(6):382-389. PubMed ID: 28817485
[TBL] [Abstract][Full Text] [Related]
13. Glucagon-like peptide 1 can directly protect the heart against ischemia/reperfusion injury.
Bose AK; Mocanu MM; Carr RD; Brand CL; Yellon DM
Diabetes; 2005 Jan; 54(1):146-51. PubMed ID: 15616022
[TBL] [Abstract][Full Text] [Related]
14. Direct effects of glucagon-like peptide-1 on myocardial contractility and glucose uptake in normal and postischemic isolated rat hearts.
Zhao T; Parikh P; Bhashyam S; Bolukoglu H; Poornima I; Shen YT; Shannon RP
J Pharmacol Exp Ther; 2006 Jun; 317(3):1106-13. PubMed ID: 16489128
[TBL] [Abstract][Full Text] [Related]
15. B-type natriuretic peptide at early reperfusion limits infarct size in the rat isolated heart.
Burley DS; Baxter GF
Basic Res Cardiol; 2007 Nov; 102(6):529-41. PubMed ID: 17896117
[TBL] [Abstract][Full Text] [Related]
16. Increased myocardial vulnerability to ischemia-reperfusion injury in the presence of left ventricular hypertrophy.
Mølgaard S; Faricelli B; Salomonsson M; Engstrøm T; Treiman M
J Hypertens; 2016 Mar; 34(3):513-23; discussion 523. PubMed ID: 26820478
[TBL] [Abstract][Full Text] [Related]
17. Both stimulation of GLP-1 receptors and inhibition of glycogenolysis additively contribute to a protective effect of oral miglitol against ischaemia-reperfusion injury in rabbits.
Iwasa M; Yamada Y; Kobayashi H; Yasuda S; Kawamura I; Sumi S; Shiraki T; Yamaki T; Ushikoshi H; Hattori A; Aoyama T; Nishigaki K; Takemura G; Fujiwara H; Minatoguchi S
Br J Pharmacol; 2011 Sep; 164(1):119-31. PubMed ID: 21426318
[TBL] [Abstract][Full Text] [Related]
18. Cordycepin, 3'-deoxyadenosine, prevents rat hearts from ischemia/reperfusion injury via activation of Akt/GSK-3β/p70S6K signaling pathway and HO-1 expression.
Park ES; Kang DH; Yang MK; Kang JC; Jang YC; Park JS; Kim SK; Shin HS
Cardiovasc Toxicol; 2014 Mar; 14(1):1-9. PubMed ID: 24178833
[TBL] [Abstract][Full Text] [Related]
19. Glucagon-like peptide-1 (GLP-1) mediates cardioprotection by remote ischaemic conditioning.
Basalay MV; Mastitskaya S; Mrochek A; Ackland GL; Del Arroyo AG; Sanchez J; Sjoquist PO; Pernow J; Gourine AV; Gourine A
Cardiovasc Res; 2016 Dec; 112(3):669-676. PubMed ID: 27702763
[TBL] [Abstract][Full Text] [Related]
20. Remote postconditioning. Brief renal ischemia and reperfusion applied before coronary artery reperfusion reduces myocardial infarct size via endogenous activation of adenosine receptors.
Kerendi F; Kin H; Halkos ME; Jiang R; Zatta AJ; Zhao ZQ; Guyton RA; Vinten-Johansen J
Basic Res Cardiol; 2005 Sep; 100(5):404-12. PubMed ID: 15965583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
